Genomics Market Size, Share & Trends Analysis Report and Segment Forecast, 2025| Grand View Research, Inc “The global genomics market size was valued at USD 13.75 billion in 2017 and is anticipated to expand at a CAGR of 9.1% over the forecast period.” The global Genomics Market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 9.1% over the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the rising trend of targeted therapies. Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and patients. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data. One of the most important factors, which are likely to have a significant impact on the market, is that how much and to what extent the medical community will make the use of available genomic information in personalized medicine. Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics, which has proven its effectiveness in enhancing personalized treatment landscape. The companies are involved in strategic alliances with global, as well as local, entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. This enabled Bristol-Myers Squibb to deploy Foundation Medicine’s molecular information solutions and comprehensive genomic profiling for identification of Follow Us: predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials. To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/genomics-market Further key findings from the study suggest: Growing interest of pharma and biotech companies in genomics is expected to drive the genomics market in coming years NGS-based services held a major share of the market due to its rapid adoption in whole genome sequencing and application of sequence databases for disease screening and prognosis The demand for these services would remain strong due to growing customer base from academic and research centers to CROs and biotech and pharma companies Use of predictive biomarkers for diagnosis and monitoring takes cancer eradication a step further Moreover, various organizations and programs are actively participating in the development of novel biomarkers for cancer diagnosis With the rising health consciousness Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. Such genetic tests enable consumers to access information about their genetics without having to visit healthcare professionals Asia Pacific is the potential regional market for genomics. It is anticipated to expand at the highest CAGR of 11.2% Major companies in the market include Beijing Genomics Institute (BGI); Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc.; 23andMe, Inc.; Danaher, Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc. Grand View Research has segmented the global genomics market on the basis of deliverables, application & technology, end use, and region: Genomics Deliverables Outlook (Revenue, USD Million, 2014 - 2025) Products o Instruments/Systems o Consumables/Reagents Services Follow Us: o Core Genomics Services o NGS-based Services o Biomarker Translation Services o Computational Services o Others Genomics Application & Technology Outlook (Revenue, USD Million, 2014 - 2025) Functional Genomics o Transfection o Real-time PCR o RNA Interference o Mutational Analysis o SNP Analysis o Microarray Analysis Epigenomics o Bisulfite Sequencing o Chromatin Immunoprecipitation (ChIP-Seq) o Methylated DNA Immunoprecipitation (MeDIP) o High Resolution Melt (HRM) o Chromatin Accessibility Assays o Microarray Analysis Pathway Analysis o Bead-based Analysis o Microarray Analysis o Real-time PCR Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Follow Us: o Biomarker Discovery o Mass Spectrometry o Real-time PCR o Microarray Analysis o Statistical Analysis o Bioinformatics o DNA Sequencing Others Genomics End-use Outlook (Revenue, USD Million, 2014 - 2025) Clinical Research Academic and Government Institutes Hospitals and Clinics Pharmaceutical and Biotechnology Companies Other End Users Genomics Regional Outlook (Revenue, USD Million, 2014 - 2025) North America o U.S. o Canada Europe o Germany o U.K. Asia Pacific o Japan o China Latin America Follow Us: o Brazil Middle East and Africa (MEA) o Follow Us: South Africa Table of Content of Genomics Market Chapter 1 Research methodology 1.1 Market segmentation & scope 1.2 Market definition 1.3 Information procurement 1.3.1 Purchased database 1.3.2 GVR’s internal database 1.3.3 Secondary sources & third party perspectives 1.3.4 Primary research 1.4 Information analysis 1.4.1 Data analysis models 1.5 Market formulation & data visualization 1.6 Data validation & publishing Chapter 2 Executive Summary 2.1 Genomics Market Outlook, 2014 - 2025 Chapter 3 Industry Outlook 3.1 Penetration & Growth Prospects Mapping 3.2 Trend analysis 3.2.1 Application trends 3.2.2 Product trends 3.2.3 End-use trends 3.2.4 Regional trends 3.3 Genomics - Market Dynamics 3.3.1 Market driver analysis 3.3.1.1 Growing integration of genomics data into clinical workflows 3.3.1.1.1 More targeted and personalized healthcare 3.3.1.1.2 Growth of newborn genetic screening programs 3.3.1.1.3 Advancements in noninvasive cancer screening 3.3.1.1.4 Military genomics 3.3.1.2 Technological advances to facilitate genomic R&D 3.3.1.2.1 Emergence of advanced genome editing techniques Follow Us: 3.3.1.2.2 Integration of new data streams 3.3.1.2.3 RNA biology 3.3.1.2.4 Single cell biology 3.3.1.3 Rising adoption of direct to consumer genomics 3.3.1.4 Success of genetic tools in agrigenomics 3.3.1.5 Increasing participation of different companies 3.3.1.6 Increase in government role and funding in genomics 3.3.2 Market restraint analysis 3.3.2.1 Issues regarding intellectual property protection, data management, and public policies 3.3.2.2 Dearth of skilled personnel 3.4 Oppurtunity Analysis 3.5 Industry Analysis - Porter's 3.5.1 Supplier power - Medium 3.5.2 Buyer power - High 3.5.3 Substitution threat - Low 3.5.4 New entrants threat - Low 3.6 Regulatory landscape: Genomics - SWOT by PEST Analysis 3.6.1 Political landscape 3.6.2 Economic landscape 3.6.3 Social landscape 3.6.4 Technology landscape 3.7 Company market share analysis 3.8 Competitive landscape 3.8.1 Strategy framework 3.8.2 Company categorization 3.8.2.1 New entrants 3.8.2.2 Mature players & leaders Chapter 4 Genomics Market Categorization: Deliverables Outlook 4.1 Genomics Market Share By Deliverabales Outlook, 2014 To 2025 4.2 Products Market, 2014 to 2025 4.2.1 Products market revenue, by North America (USD Million) Follow Us: 4.2.2 Products market revenue, by Europe (USD Million) 4.2.3 Products market revenue, by Asia Pacific (USD Million) 4.2.4 Products market revenue, by Latin America (USD Million) 4.2.5 Products market revenue, by Middle-East & Africa (USD Million) 4.2.6 Instruments/Systems market, 2014 to 2025, USD Million 4.2.6.1 Instruments/Systems market revenue, by North America (USD Million) 4.2.6.2 Instruments/Systems market revenue, by Europe (USD Million) 4.2.6.3 Instruments/Systems market revenue, by Asia Pacific (USD Million) 4.2.6.4 Instruments/Systems market revenue, by Latin America (USD Million) 4.2.6.5 Instruments/Systems market revenue, by Middle-East & Africa (USD Million) 4.2.7 Consumables/ Reagents, 2014 to 2025, USD Million 4.2.7.1 Consumables/ Reagents market revenue, by North America (USD Million) 4.2.7.2 Consumables/ Reagents market revenue, by Europe (USD Million) 4.2.7.3 Consumables/ Reagents market revenue, by Asia Pacific (USD Million) 4.2.7.4 Consumables/ Reagents market revenue, by Latin America (USD Million) 4.2.7.5 Consumables/ Reagents market revenue, by Middle-East & Africa (USD Million) 4.3 Services Market, 2014 to 2025 4.3.1 Services market revenue, by North America (USD Million) 4.3.2 Services market revenue, by Europe (USD Million) 4.3.3 Services market revenue, by Asia Pacific (USD Million) 4.3.4 Services market revenue, by Latin America (USD Million) 4.3.5 Services market revenue, by Middle-East & Africa (USD Million) 4.3.6 Core genomic services, 2014 to 2025 4.2.6.1 Core genomic services market revenue, by North America (USD Million) 4.2.6.2 Core genomic services market revenue, by Europe (USD Million) 4.2.6.3 Core genomic services market revenue, by Asia Pacific (USD Million) 4.2.6.4 Core genomic services market revenue, by Latin America (USD Million) 4.2.6.5 Core genomic services market revenue, by Middle-East & Africa (USD Million) 4.3.7 NGS based services, 2014 to 2025 4.3.7.1 NGS based services market revenue, by North America (USD Million) 4.3.7.2 NGS based services market revenue, by Europe (USD Million) Follow Us: 4.3.7.3 NGS based services market revenue, by Asia Pacific (USD Million) 4.3.7.4 NGS based services market revenue, by Latin America (USD Million) 4.3.7.5 NGS based services market revenue, by Middle-East & Africa (USD Million) 4.3.8 Biomarker translation services, 2014 to 2025 4.3.8.1 Biomarker translation services market revenue, by North America (USD Million) 4.3.8.2 Biomarker translation services market revenue, by Europe (USD Million) 4.3.8.3 Biomarker translation services market revenue, by Asia Pacific (USD Million) 4.3.8.4 Biomarker translation services market revenue, by Latin America (USD Million) 4.3.8.5 Biomarker translation services market revenue, by Middle-East & Africa (USD Million) 4.3.9 Computational services, 2014 to 2025 4.3.9.1 Computational services market revenue, by North America (USD Million) 4.3.9.2 Computational services market revenue, by Europe (USD Million) 4.3.9.3 Computational services market revenue, by Asia Pacific (USD Million) 4.3.9.4 Computational services market revenue, by Latin America (USD Million) 4.3.9.5 Computational services market revenue, by Middle-East & Africa (USD Million) 4.3.10 Other services, 2014 to 2025 4.3.10.1 Other services market revenue, by North America (USD Million) 4.3.10.2 Other services market revenue, by Europe (USD Million) 4.3.10.3 Other services market revenue, by Asia Pacific (USD Million) 4.3.10.4 Other services market revenue, by Latin America (USD Million) 4.3.10.5 Other services market revenue, by Middle-East & Africa (USD Million) Chapter 5 Genomics Market Categorization: Technology - Application Outlook 5.1 Genomics Market Share By Technology - Application Outlook, 2014 To 2025 5.2 Functional Genomics, 2014 to 2025 5.2.1 Functional genomics market revenue, by North America (USD Million) 5.2.2 Functional genomics market revenue, by Europe (USD Million) 5.2.3 Functional genomics market revenue, by Asia Pacific (USD Million) 5.2.4 Functional genomics market revenue, by Latin America (USD Million) 5.2.5 Functional genomics market revenue, by Middle-East & Africa (USD Million) 5.2.6 Transfection, 2014 to 2025 5.2.6.1 Transfection market revenue, by North America (USD Million) Follow Us: 5.2.6.2 Transfection market revenue, by Europe (USD Million) 5.2.6.3 Transfection market revenue, by Asia Pacific (USD Million) 5.2.6.4 Transfection market revenue, by Latin America (USD Million) 5.2.6.5 Transfection market revenue, by Middle-East & Africa (USD Million) 5.2.7 Real time PCR, 2014 to 2025 5.2.7.1 Real time PCR market revenue, by North America (USD Million) 5.2.7.2 Real time PCR market revenue, by Europe (USD Million) 5.2.7.3 Real time PCR market revenue, by Asia Pacific (USD Million) 5.2.7.4 Real time PCR market revenue, by Latin America (USD Million) 5.2.7.5 Real time PCR market revenue, by Middle-East & Africa (USD Million) 5.2.8 RNA interference, 2014 to 2025 5.2.8.1 RNA interference market revenue, by North America (USD Million) 5.2.8.2 RNA interference market revenue, by Europe (USD Million) 5.2.8.3 RNA interference market revenue, by Asia Pacific (USD Million) 5.2.8.4 RNA interference market revenue, by Latin America (USD Million) 5.2.8.5 RNA interference market revenue, by Middle-East & Africa (USD Million) 5.2.9 Mutational analysis, 2014 to 2025 5.2.9.1 Mutational analysis market revenue, by North America (USD Million) 5.2.9.2 Mutational analysis market revenue, by Europe (USD Million) 5.2.9.3 Mutational analysis market revenue, by Asia Pacific (USD Million) 5.2.9.4 Mutational analysis market revenue, by Latin America (USD Million) 5.2.9.5 Mutational analysis market revenue, by Middle-East & Africa (USD Million) 5.2.10 SNP analysis, 2014 to 2025 5.2.10.1 SNP analysis market revenue, by North America (USD Million) 5.2.10.2 SNP analysis market revenue, by Europe (USD Million) 5.2.10.3 SNP analysis market revenue, by Asia Pacific (USD Million) 5.2.10.4 SNP analysis market revenue, by Latin America (USD Million) 5.2.10.5 SNP analysis market revenue, by Middle-East & Africa (USD Million) 5.2.11 Microarray analysis, 2014 to 2025 5.2.11.1 Microarray analysis market revenue, by North America (USD Million) 5.2.11.2 Microarray analysis market revenue, by Europe (USD Million) Follow Us: 5.2.11.3 Microarray analysis market revenue, by Asia Pacific (USD Million) 5.2.11.4 Microarray analysis market revenue, by Latin America (USD Million) 5.2.11.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million) 5.3 Epigenetics, 2014 to 2025 5.3.1 Epigenetics market revenue, by North America (USD Million) 5.3.2 Epigenetics market revenue, by Europe (USD Million) 5.3.3 Epigenetics market revenue, by Asia Pacific (USD Million) 5.3.4 Epigenetics market revenue, by Latin America (USD Million) 5.3.5 Epigenetics market revenue, by Middle-East & Africa (USD Million) 5.3.6 Bisulfite sequencing, 2014 to 2025 5.3.6.1 Bisulfite sequencing market revenue, by North America (USD Million) 5.3.6.2 Bisulfite sequencing market revenue, by Europe (USD Million) 5.3.6.3 Bisulfite sequencing market revenue, by Asia Pacific (USD Million) 5.3.6.4 Bisulfite sequencing market revenue, by Latin America (USD Million) 5.3.6.5 Bisulfite sequencing market revenue, by Middle-East & Africa (USD Million) 5.3.7 Chromatin immunoprecipitation-sequencing (ChIP-Seq), 2014 to 2025 5.3.7.1 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by North America (USD Million) 5.3.7.2 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Europe (USD Million) 5.3.7.3 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Asia Pacific (USD Million) 5.3.7.4 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Latin America (USD Million) 5.3.7.5 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Middle-East & Africa (USD Million) 5.3.8 Methylated DNA immunoprecipitation (MeDIP), 2014 to 2025 5.3.8.1 Methylated DNA immunoprecipitation (MeDIP) market revenue, by North America (USD Million) 5.3.8.2 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Europe (USD Million) 5.3.8.3 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Asia Pacific (USD Million) Follow Us: 5.3.8.4 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Latin America (USD Million) 5.3.8.5 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Middle-East & Africa (USD Million) 5.3.9 High resolution melt, 2014 to 2025 5.3.9.1 High resolution melt market revenue, by North America (USD Million) 5.3.9.2 High resolution melt market revenue, by Europe (USD Million) 5.3.9.3 High resolution melt market revenue, by Asia Pacific (USD Million) 5.3.9.4 High resolution melt market revenue, by Latin America (USD Million) 5.3.9.5 High resolution melt market revenue, by Middle-East & Africa (USD Million) 5.3.10 Chromatin accessibility assays, 2014 to 2025 5.3.10.1 Chromatin accessibility assays market revenue, by North America (USD Million) 5.3.10.2 Chromatin accessibility assays market revenue, by Europe (USD Million) 5.3.10.3 Chromatin accessibility assays market revenue, by Asia Pacific (USD Million) 5.3.10.4 Chromatin accessibility assays market revenue, by Latin America (USD Million) 5.3.10.5 Chromatin accessibility assays market revenue, by Middle-East & Africa (USD Million) 5.3.11 Microarray analysis, 2014 to 2025 5.3.11.1 Microarray analysis market revenue, by North America (USD Million) 5.3.11.2 Microarray analysis market revenue, by Europe (USD Million) 5.3.11.3 Microarray analysis market revenue, by Asia Pacific (USD Million) 5.3.11.4 Microarray analysis market revenue, by Latin America (USD Million) 5.3.11.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million) 5.4 Pathway Analysis, 2014 to 2025 5.4.1 Pathway analysis market revenue, by North America (USD Million) 5.4.2 Pathway analysis market revenue, by Europe (USD Million) 5.4.3 Pathway analysis market revenue, by Asia Pacific (USD Million) 5.4.4 Pathway analysis market revenue, by Latin America (USD Million) 5.4.5 Pathway analysis market revenue, by Middle-East & Africa (USD Million) 5.4.6 Bead-based analysis (Bio-Plex), 2014 to 2025 5.4.6.1 Bead-based analysis (Bio-Plex) market revenue, by North America (USD Million) 5.4.6.2 Bead-based analysis (Bio-Plex) market revenue, by Europe (USD Million) Follow Us: 5.4.6.3 Bead-based analysis (Bio-Plex) market revenue, by Asia Pacific (USD Million) 5.4.6.4 Bead-based analysis (Bio-Plex) market revenue, by Latin America (USD Million) 5.4.6.5 Bead-based analysis (Bio-Plex) market revenue, by Middle-East & Africa (USD Million) 5.4.7 Microarray analysis, 2014 to 2025 5.4.7.1 Microarray analysis market revenue, by North America (USD Million) 5.4.7.2 Microarray analysis market revenue, by Europe (USD Million) 5.4.7.3 Microarray analysis market revenue, by Asia Pacific (USD Million) 5.4.7.4 Microarray analysis market revenue, by Latin America (USD Million) 5.4.7.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million) 5.4.8 Real time PCR, 2014 to 2025 5.4.8.1 Real time PCR market revenue, by North America (USD Million) 5.4.8.2 Real time PCR market revenue, by Europe (USD Million) 5.4.8.3 Real time PCR market revenue, by Asia Pacific (USD Million) 5.4.8.4 Real time PCR market revenue, by Latin America (USD Million) 5.4.8.5 Real time PCR market revenue, by Middle-East & Africa (USD Million) 5.4.9 Proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2014 to 2025 5.4.9.1 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by North America (USD Million) 5.4.9.2 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Europe (USD Million) 5.4.9.3 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Asia Pacific (USD Million) 5.4.9.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Latin America (USD Million) 5.4.9.5 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Middle-East & Africa (USD Million) 5.5 Biomarker Discovery, 2014 to 2025 5.5.1 Biomarker Discovery market revenue, by North America (USD Million) 5.5.2 Biomarker Discovery market revenue, by Europe (USD Million) 5.5.3 Biomarker Discovery market revenue, by Asia Pacific (USD Million) 5.5.4 Biomarker Discovery market revenue, by Latin America (USD Million) 5.5.5 Biomarker Discovery market revenue, by Middle-East & Africa (USD Million) Follow Us: 5.5.6 Mass spectrometry, 2014 to 2025 5.5.6.1 Mass spectrometry market revenue, by North America (USD Million) 5.5.6.2 Mass spectrometry market revenue, by Europe (USD Million) 5.5.6.3 Mass spectrometry market revenue, by Asia Pacific (USD Million) 5.5.6.4 Mass spectrometry market revenue, by Latin America (USD Million) 5.5.6.5 Mass spectrometry market revenue, by Middle-East & Africa (USD Million) 5.5.7 Real time PCR, 2014 to 2025 5.5.7.1 Real time PCR market revenue, by North America (USD Million) 5.5.7.2 Real time PCR market revenue, by Europe (USD Million) 5.5.7.3 Real time PCR market revenue, by Asia Pacific (USD Million) 5.5.7.4 Real time PCR market revenue, by Latin America (USD Million) 5.5.7.5 Real time PCR market revenue, by Middle-East & Africa (USD Million) 5.5.8 Microarray analysis, 2014 to 2025 5.5.8.1 Microarray analysis market revenue, by North America (USD Million) 5.5.8.2 Microarray analysis market revenue, by Europe (USD Million) 5.5.8.3 Microarray analysis market revenue, by Asia Pacific (USD Million) 5.5.8.4 Microarray analysis market revenue, by Latin America (USD Million) 5.2.8.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million) 5.5.9 Statistical analysis, 2014 to 2025 5.5.9.1 Statistical analysis market revenue, by North America (USD Million) 5.5.9.2 Statistical analysis market revenue, by Europe (USD Million) 5.5.9.3 Statistical analysis market revenue, by Asia Pacific (USD Million) 5.5.9.4 Statistical analysis market revenue, by Latin America (USD Million) 5.5.9.5 Statistical analysis market revenue, by Middle-East & Africa (USD Million) 5.5.10 Bioinformatics, 2014 to 2025 5.5.10.1 Bioinformatics market revenue, by North America (USD Million) 5.5.10.2 Bioinformatics market revenue, by Europe (USD Million) 5.5.10.3 Bioinformatics market revenue, by Asia Pacific (USD Million) 5.5.10.4 Bioinformatics market revenue, by Latin America (USD Million) 5.5.10.5 Bioinformatics market revenue, by Middle-East & Africa (USD Million) 5.5.11 DNA sequencing, 2014 to 2025 Follow Us: 5.5.11.1 DNA sequencing market revenue, by North America (USD Million) 5.5.11.2 DNA sequencing market revenue, by Europe (USD Million) 5.5.11.3 DNA sequencing market revenue, by Asia Pacific (USD Million) 5.5.11.4 DNA sequencing market revenue, by Latin America (USD Million) 5.5.11.5 DNA sequencing market revenue, by Middle-East & Africa (USD Million) 5.6 Others, 2014 to 2025 5.6.1 Others market revenue, by North America (USD Million) 5.6.2 Others market revenue, by Europe (USD Million) 5.6.3 Others market revenue, by Asia Pacific (USD Million) 5.6.4 Others market revenue, by Latin America (USD Million) 5.6.5 Others market revenue, by Middle-East & Africa (USD Million) Chapter 6 Genomics Market Categorization: End-use Outlook 6.1 Genomics Market Share by End-Use, 2014 to 2025 6.2 Clinical & Research Laboratories, 2014 to 2025 6.2.1 Clinical & research laboratories market revenue, by North America (USD Million) 6.2.2 Clinical & research laboratories market revenue, by Europe (USD Million) 6.2.3 Clinical & research laboratories market revenue, by Asia Pacific (USD Million) 6.2.4 Clinical & research laboratories market revenue, by Latin America (USD Million) 6.2.5 Clinical & research laboratories market revenue, by Middle-East & Africa (USD Million) 6.3 Academic and Government Institutes, 2014 to 2025 6.3.1 Academic & government institutes market revenue, by North America (USD Million) 6.3.2 Academic & government institutes market revenue, by Europe (USD Million) 6.3.3 Academic & government institutes market revenue, by Asia Pacific (USD Million) 6.3.4 Academic & government institutes market revenue, by Latin America (USD Million) 6.3.5 Academic & government institutes market revenue, by Middle-East & Africa (USD Million) 6.4 Hospitals and Clinics, 2014 to 2025 6.4.1 Hospitals & clinics market revenue, by North America (USD Million) 6.4.2 Hospitals & clinics market revenue, by Europe (USD Million) 6.4.3 Hospitals & clinics market revenue, by Asia Pacific (USD Million) 6.4.4 Hospitals & clinics market revenue, by Latin America (USD Million) 6.4.5 Hospitals & clinics market revenue, by Middle-East & Africa (USD Million) Follow Us: 6.5 Pharmaceutical and Biotechnology Companies, 2014 to 2025 6.5.1 Pharmaceutical & biotechnology companies market revenue, by North America (USD Million) 6.5.2 Pharmaceutical & biotechnology companies market revenue, by Europe (USD Million) 6.5.3 Pharmaceutical & biotechnology companies market revenue, by Asia Pacific (USD Million) 6.5.4 Pharmaceutical & biotechnology companies market revenue, by Latin America (USD Million) 6.5.5 Pharmaceutical & biotechnology companies market revenue, by Middle-East & Africa (USD Million) 6.6 Other End Users, 2014 to 2025 6.6.1 Other end users market revenue, by North America (USD Million) 6.6.2 Other end users market revenue, by Europe (USD Million) 6.6.3 Other end users market revenue, by Asia Pacific (USD Million) 6.6.4 Other end users market revenue, by Latin America (USD Million) 6.6.5 Other end users market revenue, by Middle-East & Africa (USD Million) Chapter 7 Genomics Market Categorization: Regional Outlook 7.1 Genomics Market Share By Region, 2014 to 2025 7.2 North America 7.2.1 Genomics market revenue, (USD Million), by U.S. 7.2.2 Genomics market revenue, (USD Million), by Canada 7.2.3 U.S. 7.2.3.1 Genomics market, by deliverables 7.2.3.2 Genomics market, by application & technology 7.2.3.3 Genomics market, by end-use 7.2.4 Canada 7.2.4.1 Genomics market, by deliverables 7.2.4.2 Genomics market, by application & technology 7.2.4.3 Genomics market, by end-use 7.3 Europe 7.3.1 Genomics market revenue, (USD Million), by Germany 7.3.2 Genomics market revenue, (USD Million), by U.K. 7.3.3 Germany 7.3.3.1 Genomics market, by deliverables Follow Us: 7.3.3.2 Genomics market, by application & technology 7.3.3.3 Genomics market, by end-use 7.3.4 U.K. 7.3.4.1 Genomics market, by deliverables 7.3.4.2 Genomics market, by application & technology 7.3.4.3 Genomics market, by end-use 7.4 Asia Pacific 7.4.1 Genomics market revenue, (USD Million), by Germany 7.4.2 Genomics market revenue, (USD Million), by U.K. 7.4.3 Japan 7.4.3.1 Genomics market, by deliverables 7.4.3.2 Genomics market, by application & technology 7.4.3.3 Genomics market, by end-use 7.4.4 China 7.4.4.1 Genomics market, by deliverables 7.4.4.2 Genomics market, by application & technology 7.4.4.3 Genomics market, by end-use 7.5 Latin America 7.5.1 Genomics market revenue, (USD Million), by Brazil 7.5.2 Brazil 7.5.2.1 Genomics market, by deliverables 7.5.2.2 Genomics market, by application & technology 7.5.2.3 Genomics market, by end-use 7.6 MEA 7.6.1 Genomics market revenue, (USD Million), by MEA 7.6.2 South Africa 7.6.2.1 Genomics market, by deliverables 7.6.2.2 Genomics market, by application & technology 7.6.2.3 Genomics market, by end-use Chapter 8 Company Profiles 8.1 Company Profiles Follow Us: 8.1.1 Thermo Fisher Scientific, Inc. 8.1.1.1 Company overview 8.1.1.1.1 Life Technologies Corp. 8.1.1.1.2 Affymetrix, Inc. 8.1.1.1.3 Applied Biosystems 8.1.1.2 Financial performance 8.1.1.2.1 Financial performance (Affymetrix) 8.1.1.3 Product benchmarking 8.1.1.4 Strategic initiatives 8.1.2 Agilent Technologies 8.1.2.1 Company overview 8.1.2.2 Financial performance 8.1.2.3 Product benchmarking 8.1.2.4 Strategic initiatives 8.1.3 BGI 8.1.3.1 Company overview 8.1.3.1.1 Complete Genomics Incorporated 8.1.3.2 Financial performance 8.1.3.3 Product benchmarking 8.1.3.4 Strategic initiatives 8.1.4 Bio-Rad Laboratories, Inc. 8.1.4.1 Company overview 8.1.4.1.1 GnuBIO 8.1.4.2 Financial performance 8.1.4.3 Product benchmarking 8.1.4.4 Strategic initiatives 8.1.5 Danaher 8.1.5.1 Company overview 8.1.5.1.1 Beckman Coulter, Inc. 8.1.5.1.2 Cepheid 8.1.5.2 Financial performance Follow Us: 8.1.5.3 Product benchmarking 8.1.5.4 Strategic initiatives 8.1.6 F. Hoffmann-La Roche Ltd. 8.1.6.1 Company overview 8.1.6.1.1 454 Life Sciences (Roche Diagnostics Corporation) 8.1.6.1.2 Genentech, Inc. 8.1.6.1.3 Ventana Medical Systems, Inc. 8.1.6.2 Financial performance 8.1.6.2.1 Financial performance 8.1.6.3 Product benchmarking 8.1.6.4 Strategic initiatives 8.1.7 GE Healthcare 8.1.7.1 Company overview 8.1.7.2 Financial performance 8.1.7.3 Product benchmarking 8.1.7.4 Strategic initiatives 8.1.8 Illumina, Inc. 8.1.8.1 Company overview 8.1.8.2 Financial performance 8.1.8.3 Product benchmarking 8.1.8.4 Strategic initiatives 8.1.9 Oxford Nanopore Technologies 8.1.9.1 Company overview 8.1.9.2 Financial performance 8.1.9.3 Product benchmarking 8.1.9.4 Strategic initiatives 8.1.10 Pacific Biosciences of California, Inc. 8.1.10.1 Company overview 8.1.10.2 Financial performance 8.1.10.3 Product benchmarking 8.1.10.4 Strategic initiatives Follow Us: 8.1.11 QIAGEN 8.1.11.1 Company overview 8.1.11.2 Financial performance 8.1.11.3 Product benchmarking 8.1.11.4 Strategic initiatives 8.1.12 Quest Diagnostics Incorporated 8.1.12.1 Company overview 8.1.12.2 Financial performance 8.1.12.3 Product benchmarking 8.1.12.4 Strategic initiatives 8.1.13 Foundation Medicine, Inc. 8.1.13.1 Company overview 8.1.13.2 Financial performance 8.1.13.3 Product benchmarking 8.1.13.4 Strategic initiatives 8.1.14 Myriad Genetics, Inc. 8.1.14.1 Company overview 8.1.14.2 Financial performance 8.1.14.3 Product benchmarking 8.1.14.4 Strategic initiatives 8.1.15 Eppendorf AG 8.1.15.1 Company overview 8.1.15.2 Financial performance 8.1.15.3 Product benchmarking 8.1.16 Eurofins Scientific 8.1.16.1 Company overview 8.1.16.2 Financial performance 8.1.16.3 Product benchmarking 8.1.16.4 Strategic initiatives 8.1.17 Color Genomics, Inc. 8.1.17.1 Company overview Follow Us: 8.1.17.2 Financial performance 8.1.17.3 Product benchmarking 8.1.17.4 Strategic initiatives 8.1.18 23andMe, Inc. 8.1.18.1 Company overview 8.1.18.2 Financial performance 8.1.18.3 Product benchmarking 8.1.18.4 Strategic initiatives Follow Us: About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Follow Us:
The global genomics market size is expected to reach USD 27.6 billion by 2025
© Copyright 2024 Paperzz
